Stockreport

BrainStorm Cell Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement

Brainstorm Cell Therapeutics Inc.  (BCLI) 
Last brainstorm cell therapeutics inc. earnings: 11/14 06:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.brainstorm-cell.com
PDF NEW YORK, Oct. 30, 2024 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, today [Read more]